Stock listing
Cynata Therapeutics Limited
Selected listing: CYYNF · OTC · USD · US
Cynata Therapeutics Limited (OTC:CYYNF), Health Technology. Latest release Sep 30, 2026: R&D Tax Incentive Loan Facility Extension.
- Ticker
- OTC:CYYNF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Cynata Therapeutics Limited
The company focuses on developing innovative cell therapy solutions. Cynata is known for its proprietary Cymerus technology, which enables the production of large quantities of therapeutic cells.
Latest news from Cynata Therapeutics Limited
R&D Tax Incentive Loan Facility Extension
September 29, 2026
Notification under Listing Rule 4.3D
September 23, 2026
Appendix 4E & Preliminary Final Report
August 30, 2026
June 2026 Quarterly Activity Report & Appendix 4C
July 29, 2026
Board, Management Changes, Expenditure Reductions, RDTI Loan
July 5, 2026
Research Cynata Therapeutics Limited
Cynata Therapeutics Limited company profile
View the public company page for Cynata Therapeutics Limited on 6ix.
Cynata Therapeutics Limited news
Read company news and market updates connected to Cynata Therapeutics Limited.
Cynata Therapeutics Limited investor events
Find investor webinars, events, and replay context for Cynata Therapeutics Limited.
Alternate listings
CYP:ASX
AU · AUD
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is CYYNF:OTC.
51S:FWB
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is CYYNF:OTC.
51S:HAM
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is CYYNF:OTC.
51S:MUN
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is CYYNF:OTC.
51S:SWB
DE · EUR
Alternate listing for Cynata Therapeutics Limited; the primary context on this page is CYYNF:OTC.